In summary, our study identifies the upstream modulator and downstream mediator of KDM4C and reveals that targeting KDM4C via blocking TGF-β2/Smad signaling impairs tumorigenesis and enhances radiosensitivity in lung cancer (Fig. 8i). Here, KDM4C is linked to lung cancer.